Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT02704403 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
2157
Enrollment
INDUSTRY
Sponsor class

Stopped Study did not meet the predefined primary surrogate efficacy endpoint, no safety issues identified

Conditions

Interventions

Sponsor

Genfit